Educating physicians about PSA reduction goals may increase the number of patients with mCSPC receiving first-line treatment ...

The WOLVERINE study analyzed five trials and found metastasis-directed therapy -- primarily radiation -- may delay castration resistance and improve other long-term outcomes in prostate cancer. While ...

A 68-year-old man with prostate cancer develops penile metastases, a rare but serious complication, reinforcing the need for ...

Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

Jacob E. Berchuck, MD, highlights challenges in adopting liquid biopsy for PSMA expression and its potential to revolutionize precision medicine in prostate cancer.

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

Scott Eggener, MD, gave a talk at the LUGPA annual meeting titled “Leveraging Cutting-Edge Technologies to Enhance Prostate Cancer Treatments.” ...

Erectile dysfunction is common after prostate cancer treatment. A new study shows that aerobic exercise and strength training ...

Prostate cancer is a silent threat that hits Black men the hardest leading to higher mortality rates than in any other group.

Sponsored by City Of Hope Cancer Center Prostate cancer is the second-most common cancer among men in the U.S., it’s ...

Investigators assess the impact of increasing persistent PSA levels on prostate cancer–specific mortality and all-cause ...

Metastatic prostate cancer patients in the Capital Region now have a new treatment option at Ochsner MD Anderson Cancer ...